FDA LAW BLOG--October 07, 2013 The Shutdown: An Update on FDA Activities By Kurt R. Karst –

     

We’re now entering the second week of the shutdown of the federal government (or “the lapse period” as some have called it), and there does not appear to be an end in sight.  In fact, the environment in Washington, D.C. has been described as “toxic.”  On the FDA front, confusion (both in and out of the Agency) seems to have been the state of affairs for several days last week.  What’s on and what’s off for FDA has been an ongoing topic of discussion since before the shutdown and after FDA issued an initial statement on affected activities (see our previous posthere).